Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MGI, SuperGen deal

MOGN licensed exclusive worldwide rights to develop, manufacture and market SUPG's

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE